WallStSmart
FBRX

Forte Biosciences Inc

NASDAQ: FBRX · HEALTHCARE · BIOTECHNOLOGY

$28.03
+6.23% today

Updated 2026-04-29

Market cap
$537.90M
P/E ratio
P/S ratio
EPS (TTM)
$-4.71
Dividend yield
52W range
$6 – $36
Volume
0.3M

Forte Biosciences Inc (FBRX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
2 of 8
Last 8 quarters
Avg EPS surprise
-70.9%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-39.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-3.7%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
-10.1%
2025-12-31
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-31$-1.91$26.32$24.86-5.5%
2025-12-31$-1.45-26.4%$26.27$23.61-10.1%
2025-11-14$-0.99-1137.5%$13.84$14.49+4.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-1.91
2025-12-31$-1.15$-1.45-26.4%
2025-09-30$-0.08$-0.99-1137.5%
2025-06-30$-1.11$-0.96+13.5%
2025-03-31$-0.95$-1.37-44.2%
2024-12-31$-0.14$-1.17-735.7%$38000.00+533.3%
2024-09-30$-7.12$-4.54+36.2%
2024-06-30$-0.17$-0.27-58.8%
2024-03-31$-0.16$-0.16+0.0%$6000.00
2023-12-31$-0.28$-0.19+32.1%$6000.00
2023-09-30$-0.57$-0.26+54.4%

Frequently asked questions

Has Forte Biosciences Inc beaten earnings estimates?
Forte Biosciences Inc has beaten Wall Street EPS estimates in 2 of its last 8 quarterly reports, with an average EPS surprise of -70.9% over the last 3 quarters.
How does FBRX stock react to earnings?
FBRX stock has moved an average of -3.7% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.